Related Experiment Videos
An interview with Kirk S. Schroeder, President, Essen Instruments
Assay and Drug Development Technologies
|April 20, 2004
Summary
Kirk Schroeder co-developed Fluorescence Imaging Plate Reader (FLIPR) technology for high throughput cell-based assays. Essen Instruments is developing an electrophysiology platform for high throughput patch-clamp experiments and sterile dispensing products.
Area of Science:
- Biotechnology
- Biophysics
- Assay Development
Background:
- Kirk Schroeder, co-founder of Essen Instruments, is a co-developer of Fluorescence Imaging Plate Reader (FLIPR) technology.
- FLIPR technology enables high-throughput cell-based assays.
- Schroeder's background includes degrees in physics and electrical engineering.
Discussion:
- Essen Instruments focuses on developing innovative technologies for biological research.
- The company is advancing high-throughput screening methods.
- Product development includes both assay platforms and dispensing systems.
Key Insights:
- The development of FLIPR technology has significantly impacted high-throughput screening.
- Essen Instruments is expanding into electrophysiology with their Ion Works platform.
- The company also offers Pipeline products for sterile dispensing.
Outlook:
- Further development of the Ion Works electrophysiology platform is anticipated.
- Essen Instruments aims to provide comprehensive solutions for biological research.
- The company's innovations support advancements in drug discovery and cellular analysis.